The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
LEEEF · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | LEEEF | NUWE | MRNA | ATPC |
|---|---|---|---|---|
| Moat Score (0–100) | 42 (highest) | 42 (highest) | 42 (highest) | 42 (highest) |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 70 (highest) | 46 | 50 | 20 |
| Pricing power | 46 | 64 | 70 (highest) | 70 (highest) |
| Returns on capital | — | 0 | 10 (highest) | 0 |
| Balance-sheet safety | 28 | 55 (highest) | 55 (highest) | 55 (highest) |
| Capital discipline | 24 | 44 | 24 | 64 (highest) |
| Price vs. high estimate | No price data | No price data | No price data | No price data |
| Market cap | $55.2M | $5.1M | $23.4B | $2.6M |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |